Modulation of monocarboxylate transporter 8 oligomerization by specific pathogenic mutations
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The monocarboxylate transporter 8 (MCT8) is a member of the major facilitator superfamily (MFS). These membrane-spanning proteins facilitate translocation of a variety of substrates, MCT8 specifically transports iodothyronines. Mutations in MCT8 are the underlying cause of severe X-linked psychomotor retardation. At the molecular level, such mutations led to deficiencies in substrate translocation due to reduced cell-surface expression, impaired substrate binding, or decreased substrate translocation capabilities. However, the causal relationships between genotypes, molecular features of mutated MCT8, and patient characteristics have not yet been comprehensively deciphered. We investigated the relationship between pathogenic mutants of MCT8 and their capacity to form dimers (presumably oligomeric structures) as a potential regulatory parameter of the transport function of MCT8. Fourteen pathogenic variants of MCT8 were investigated in vitro with respect to their capacity to form oligomers. Particular mutations close to the substrate translocation channel (S194F, A224T, L434W, and R445C) were found to inhibit dimerization of MCT8. This finding is in contrast to those for other transporters or transmembrane proteins, in which substitutions predominantly at the outer-surface inhibit oligomerization. Moreover, specific mutations of MCT8 located in transmembrane helix 2 (del230F, V235M, and ins236V) increased the capacity of MCT8 variants to dimerize. We analyzed the localization of MCT8 dimers in a cellular context, demonstrating differences in MCT8 dimer formation and distribution. In summary, our results add a new link between the functions (substrate transport) and protein organization (dimerization) of MCT8, and might be of relevance for other members of the MFS. Finally, the findings are discussed in relationship to functional data combined with structural–mechanistical insights into MCT8.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter
Friesema, E. C. H., Ganguly, S., Abdalla, A., Fox, J. E. M., Halestrap, A. P., & Visser, T. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300909200 · Cited by 725
Friesema, E. C., Grueters, A., Biebermann, H., Krude, H., von Moers, A., Reeser, M., Barrett, T. G., Mancilla, E. E., Svensson, J., Kester, M. H., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17226-7 · Cited by 709 · cited 1×
“non-insulin-dependent diabetes mellitus (Watson & Pessin 2001), and mutations of the monocarboxylate transporter 8 (MCT8) are the underlying cause of a severe X-linked psychomotor retardation, known as the Allan–Herndon– Dudley syndrome (Friesema et al. 2004).”
BackgroundSelf-citationMinireview: Thyroid Hormone Transporters: The Knowns and the Unknowns
Visser, W. E., Friesema, E. C. H., & Visser, T. J. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0095 · Cited by 390 · cited 2×
“molecular reasons for this phenomenon remain the subject of intense research (Visser et al. 2011).”
BackgroundThyroid hormone transporters in health and disease
Jansen, J., Friesema, E. C. H., Milici, C., & Visser, T. J. (2005) · Thyroid · doi:10.1089/thy.2005.15.757 · Cited by 181
Mutations in MCT8 in patients with Allan-Herndon-Dudley-syndrome affecting its cellular distribution
Kersseboom, S., Kremers, G.-J., Friesema, E. C. H., Visser, W. E., Klootwijk, W., Peeters, R. P., & Visser, T. J. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1356 · Cited by 45
Capri, Y., Friesema, E. C. H., Kersseboom, S., Touraine, R., Monnier, A., Eymard-Pierre, E., Des Portes, V., De Michele, G., Brady, A. F., Boespflug-Tanguy, O., et al. (2013) · Human Mutation · doi:10.1002/humu.22331 · Cited by 33
Cited by
New insights into thyroid hormone action
Mendoza, A., & Hollenberg, A. N. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.012 · Cited by 281
Groeneweg, S., van Geest, F. S., Peeters, R. P., Heuer, H., & Visser, W. E. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz008 · Cited by 216
Auto-regulation of the thyroid gland beyond classical pathways
Brix, K., Szumska, J., Weber, J., Qatato, M., Venugopalan, V., Al-Hashimi, A., & Rehders, M. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1080-2969 · Cited by 21
Self-citationFischer, J., Kleinau, G., Rutz, C., Zwanziger, D., Khajavi, N., Müller, A., Rehders, M., Brix, K., Worth, C. L., Führer, D., et al. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2728-1 · Cited by 18
Self-citation
Metadata
- Authors
- Fischer, J., Kleinau, G., Müller, A., Kühnen, P., Zwanziger, D., Kinne, A., Rehders, M., Moeller, L. C., Führer, D., Grüters, A., Krude, H., Brix, K., & Biebermann, H.
- Venue
- Journal of Molecular Endocrinology
- Publisher
- Bioscientifica
- Published
- 2015-02
- Volume
- 54
- Issue
- 1
- Pages
- 39-50
- ISSN
- 0952-5041 (ISSN-L)
- 1479-6813
- OpenAlex
- W2331598401
- Cited by
- 18
- References
- 6
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modulation of monocarboxylate transporter 8 oligomerization by specific pathogenic mutations. https://app.cochat.ai/papers/10.1530/jme-14-0272
- The paper
- Fischer, J., Kleinau, G., Müller, A., Kühnen, P., Zwanziger, D., Kinne, A., Rehders, M., Moeller, L. C., Führer, D., Grüters, A., Krude, H., Brix, K., & Biebermann, H. (2015). Modulation of monocarboxylate transporter 8 oligomerization by specific pathogenic mutations. Journal of Molecular Endocrinology. https://doi.org/10.1530/jme-14-0272
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.